Wyoming | Newborn Screening

State Newborn Screening Panel

3-hydroxy-3-methylglutaryl-CoA lyase deficiency
3-methylcrotonyl-CoA carboxylase deficiency
3-methylglutaconic aciduria
Arginase deficiency
Argininosuccinic acidemia
Beta-ketothiolase deficiency
Biotinidase
Carnitine acylcarnitine translocase deficiency
Carnitine palmitoyltransferase deficiency 1a
Carnitine palmitoyltransferase II deficiency
Carnitine uptake defect
Citrullinemia, type I
Citrullinemia, type II
Congenital adrenal hyperplasia
Congenital hypothyroidism
Critical congenital heart disease
Cystic fibrosis
Galactosemia
Glutaric acidemia type I
Glutaric acidemia type II
Hearing loss
Hemoglobin SC disease
Homocystinuria
Hypermethioninemia
Isovaleric acidemia
Long-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency
Malonic acidemia
Maple syrup urine disease
Medium-chain acyl-CoA dehydrogenase deficiency
Methylmalonic acidemia (cobalamin disorders, vitamin B12 disorders)
Methylmalonic acidemia (methylmalonyl-CoA mutase)
Methylmalonic acidemia with homocystinuria
Multiple carboxylase deficiency
Phenylketonuria
Propionic acidemia
Severe combined immunodeficiency
Short-chain acyl-CoA dehydrogenase deficiency
Sickle cell anemia
Spinal muscular atrophy
Trifunctional protein deficiency
Tyrosinemia, type I
Tyrosinemia, type II
Tyrosinemia, type III
Very long-chain acyl-CoA dehydrogenase deficiency

In this state, babies undergo a second screening step when they are around two weeks old. This second screening usually happens in a health care provider’s office. It can help find babies who have conditions that are hard to detect in the first days of life but that still benefit from early treatment or intervention.

Contacts and Support

State Newborn Screening Program

Wyoming Newborn Screening Program

Phone: 307-777-6297

FAX: 307-777-7215

Wyoming Newborn Screening Program Website

Additional Resources

For a listing of general support, advocacy, and informational resources for Newborn Screening, visit the Resources page.

Date Last Reviewed:

June 2022